HerniaMeshInjuries.

Mesh-based hernia repair is now the default for inguinal, ventral, incisional, and most recurrent hernias. The primary rationale is lower recurrence — studies consistently show tissue-only repairs recur at higher rates than mesh-reinforced repairs. The range of available meshes and surgical approaches:

• Synthetic polypropylene mesh. The workhorse material — durable, inexpensive, well-tolerated by most patients. Used for inguinal and ventral repairs.
• Polyester mesh. Common European option with similar profile to polypropylene.
• ePTFE mesh. Smoother surface, reduced adhesion profile when placed intra-abdominally. More expensive.
• Composite mesh. Multi-layer products with a tissue-facing barrier to reduce adhesion when mesh contacts bowel.
• Biologic mesh. Derived from human, porcine, or bovine tissue; degrades over time and is replaced by host tissue. Used in contaminated fields where synthetic mesh is contraindicated.
• Self-fixating mesh. Incorporates micro-hooks or adhesive to reduce the need for tack or suture fixation.

Different products suit different clinical situations. Selecting the wrong product for the wrong hernia is one of the recurring mechanisms of surgical malpractice in this space.

The complications that lead to hernia mesh litigation and their typical presentations:

• Chronic postoperative pain. Peer-reviewed estimates place significant chronic pain at 10-20% of inguinal mesh repairs. Causes include nerve entrapment (ilioinguinal, iliohypogastric, genitofemoral), mesh contraction pulling on fixation points, and mesh hematoma. Some respond to nerve blocks or neurectomy; some require mesh removal.
• Mesh migration. Mesh that moves from its original placement, sometimes into adjacent tissue or organ. Can cause obstruction, pain, or erosion.
• Mesh erosion. Most concerning when mesh erodes into bowel — can create fistulas, obstructions, or perforations. Often requires mesh removal and bowel resection.
• Bowel adhesion. Mesh placed intra-abdominally without an anti-adhesive barrier can adhere to bowel, creating obstruction or fistula. This is the mechanism underlying several major product liability cases.
• Mesh infection. Often chronic and indolent, presenting as persistent drainage or unhealed wound. Usually requires mesh removal.
• Hernia recurrence. When the repair fails, often due to inadequate mesh size, inadequate fixation, or patient factors not adequately addressed.

The analytical split between the two pathways:

• Product liability. The mesh itself is the problem — a design that predictably produced adhesions, manufacturing defects, or inadequate warnings about known risks. Defendants are manufacturers. Cases often proceed as multi-district litigation.
• Surgical malpractice — product selection. The surgeon chose a product inappropriate for the specific hernia — intra-abdominal mesh without anti-adhesive barrier, undersized mesh for a large defect, synthetic mesh in a contaminated field.
• Surgical malpractice — placement and fixation. The mesh was placed or fixed in a way that deviated from technique — fixation tacks into nerves, inadequate overlap of the defect, improper mesh orientation.
• Surgical malpractice — patient selection. Contraindications that should have been considered — severe comorbidity, active infection, tissue quality — were not adequately addressed.
• Surgical malpractice — follow-up. Imaging showing mesh erosion, adhesions, or migration was available but not acted on, and the delay transformed a manageable complication into a catastrophic one.

The distinction matters. A product liability case proceeds against the manufacturer in federal court, often as part of an MDL. A malpractice case proceeds against the surgeon and hospital in state court under Florida’s § 766 pre-suit framework. The timelines, the venues, the defendants, and the potential recoveries differ.

Patient-selection issues that recur in hernia mesh litigation:

• Active or prior contaminated field. Synthetic mesh in a field of active infection or gross contamination is generally contraindicated. Biologic mesh or delayed staged repair is often the appropriate alternative.
• Obesity. Very obese patients have higher rates of mesh complications; pre-operative weight loss is sometimes recommended before elective mesh repair.
• Diabetes or immunosuppression. Elevates infection and wound complication rates. Risk-benefit discussion and, in some cases, alternative approaches are indicated.
• Smoking. Significantly raises mesh infection and wound complication risk. Pre-operative cessation is often recommended for elective repair.
• Prior mesh complications. A patient who has had a mesh explant for infection or erosion carries a different risk profile for further mesh-based repair.
• Hernia location and size. Some defects are unsuited to mesh-based repair; some benefit from component separation or abdominal wall reconstruction rather than simple mesh placement.

When the pre-operative workup identified a risk factor and the surgical plan did not adequately account for it, the case builds from there.

Recurring follow-up failure patterns:

• Dismissed post-operative pain. Chronic pain is common after mesh repair; dismissing all of it as normal misses the subset that reflects nerve entrapment or mesh contraction amenable to treatment.
• Ignored imaging findings. CT scans done for unrelated reasons occasionally identify mesh migration, hematoma, or erosion that was never communicated or acted on.
• Missed recurrence. A bulge at the original repair site assessed as a seroma or "just swelling" turns out to be a recurrent hernia needing repair.
• Missed fistula. Enterocutaneous fistula from mesh erosion presenting as drainage attributed to superficial infection rather than the deeper process.
• Delayed diagnosis of mesh infection. Chronic drainage or non-healing wound over a mesh repair attributed to superficial infection rather than the deeper mesh infection that actually requires explant.

The damages categories typical in hernia mesh malpractice cases:

• Past medical expenses. Revision surgery, mesh explant, abdominal wall reconstruction, potential bowel resection, hospitalization, IV antibiotics.
• Future medical expenses. Chronic pain management, potential further revisions, ostomy care in some cases, ongoing surveillance.
• Lost earnings. Often prolonged because mesh explant and reconstruction has a longer recovery than the original repair.
• Lost earning capacity. Where chronic pain or functional impairment prevents return to pre-injury work.
• Pain and suffering. Chronic post-operative pain after mesh repair is often debilitating and long-standing. Uncapped in Florida after Kalitan (2017).
• Disfigurement. Scarring from multiple surgeries, potential ostomy sites, chronic wound sequelae.
• Loss of consortium. Where the injury has materially affected marital or domestic relationships.

Documentary sources that hernia mesh cases turn on:

• Operative report. Product, size, placement technique, fixation method, any intraoperative concerns.
• Implant card. Product name, size, lot number, manufacturer. Central to both product liability and malpractice analysis.
• Pre-operative records. Imaging of the hernia, informed consent documentation, discussion of alternatives.
• Follow-up records. Post-operative visits, reported symptoms, imaging, treatment decisions.
• Revision surgery operative reports. Often describe the mesh complication in detail and may characterize how it arose.
• Pathology reports. If mesh was removed — characterize the state of the mesh and any infection or tissue reaction.

Florida Statute § 766.102 requires a corroborating expert affidavit before suit is filed.